Cargando…
Leprosy : epidemiology, treatment strategies and current challenges in research /
Leprosy is a chronic granulomatous infectious disease that affects the skin and peripheral nerves; its causative agent is the obligate intracellular bacillus Mycobacterium leprae. The etiological diagnosis of the disease in its paucibacillary (PB) form still needs to be improved, because the bacillu...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Biomedical,
[2014]
|
| Colección: | Allergies and infectious diseases.
Nova biomedical. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn890934410 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 140715s2014 nyua ob 001 0 eng | ||
| 010 | |a 2020676561 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d E7B |d OCLCF |d EBLCP |d YDXCP |d DEBSZ |d AGLDB |d VTS |d AU@ |d STF |d K6U |d N$T |d OCLCO |d OCLCQ | ||
| 019 | |a 900005800 |a 923676378 |a 928195843 |a 992887035 | ||
| 020 | |a 9781633216716 |q (ebook) | ||
| 020 | |a 1633216713 | ||
| 020 | |a 1633216683 | ||
| 020 | |a 9781633216686 | ||
| 029 | 1 | |a DEBBG |b BV042794209 | |
| 029 | 1 | |a DEBBG |b BV043782750 | |
| 029 | 1 | |a DEBSZ |b 472845497 | |
| 035 | |a (OCoLC)890934410 |z (OCoLC)900005800 |z (OCoLC)923676378 |z (OCoLC)928195843 |z (OCoLC)992887035 | ||
| 050 | 0 | 0 | |a RC154 |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.998 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Leprosy : |b epidemiology, treatment strategies and current challenges in research / |c Roger S. Kopp, editor. |
| 264 | 1 | |a New York : |b Nova Biomedical, |c [2014] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Allergies and infectious diseases | |
| 490 | 1 | |a Nova biomedical | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a LEPROSY: EPIDEMIOLOGY, TREATMENT STRATEGIES AND CURRENT CHALLENGES IN RESEARCH; LEPROSY: EPIDEMIOLOGY, TREATMENT STRATEGIES AND CURRENT CHALLENGES IN RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Leprosy: From Clinical Diagnosis to Benchwork; Abstract; PCR with Primers for MntH (ML2098) Gene Amplification Sensitively and Specifically Identifies M. Leprae in Human Samples; References; Leprosy and Thromboembolic Phenomena; References; Genetic Markers on Leprosy. | |
| 505 | 8 | |a Association of the Solute Carrier Family 11 Member 1 Gene (SLC11A1/NRAMP1) polymorphisms with Susceptibility to LeprosyReferences; Genetic Polymorphisms of Innate and Adaptive Immune Response and Susceptibility to Leprosy; Conclusion; Acknowledgments; References; Chapter 2: In Vivo and In Vitro Evidence on the Relationship between Antiphospholipid Antibodies and Leprosy; Abstract; Introduction; Prevalence of aPL in Leprosy; Specificity of aPL in Leprosy Patients; Do aPL Positive Leprosy Patients Share Páthogenic Mechanisms with APS Patients?; In Vivo Studies Linking aPL with Leprosy. | |
| 505 | 8 | |a ConclusionReferences; Chapter 3: Leprosy and Pregnancy: A Epidemiological and Social Study in the Pará State, North of Brazil; Abstract; Introduction; Concept and Etiology; Classification -- Clinic -- Reactions; Treatment and Prophylactic Actions; Surveillance of Leprosy; Leprosy and Pregnancy; References; Chapter 4: The Potential of Antimicrobial Peptide Inhibitors (APIs) and Elicitors (APEs) in Leprosy Treatment; Abstract; Introduction; Side Effects in the Traditional; Treatment of Leprosy; The Role of Antimicrobial Peptides in Leprosy; Role of Defensins; Role of Hepcidin. | |
| 505 | 8 | |a Role of Cathelicidin LL-37Antimicrobial Peptide Inhibitors; As Potential Treatment of Leprosy; Antimicrobial Peptide Elicitors; As Potential Treatment of Leprosy; Conclusion; Acknowledgments; References; Index. | |
| 520 | |a Leprosy is a chronic granulomatous infectious disease that affects the skin and peripheral nerves; its causative agent is the obligate intracellular bacillus Mycobacterium leprae. The etiological diagnosis of the disease in its paucibacillary (PB) form still needs to be improved, because the bacillus is not yet cultivable. This book discusses the current challenges in the research of leprosy, as well as the epidemiology and treatment strategies available. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Leprosy. | |
| 650 | 2 | |a Leprosy | |
| 650 | 6 | |a Lèpre. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Leprosy. |2 fast |0 (OCoLC)fst00996325 | |
| 700 | 1 | |a Kopp, Roger S., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Leprosy. |d New York : Nova Science Publishers, Inc., [2014] |z 9781633216686 |w (DLC) 2014946013 |
| 830 | 0 | |a Allergies and infectious diseases. | |
| 830 | 0 | |a Nova biomedical. | |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=833074 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL2119904 | ||
| 938 | |a ebrary |b EBRY |n ebr10913170 | ||
| 938 | |a EBSCOhost |b EBSC |n 833074 | ||
| 938 | |a YBP Library Services |b YANK |n 11975967 | ||
| 994 | |a 92 |b IZTAP | ||